P
Pia M. Villa
Researcher at University of Helsinki
Publications - 93
Citations - 3335
Pia M. Villa is an academic researcher from University of Helsinki. The author has contributed to research in topics: Pregnancy & Preeclampsia. The author has an hindex of 26, co-authored 84 publications receiving 2475 citations. Previous affiliations of Pia M. Villa include Helsinki University Central Hospital.
Papers
More filters
Journal ArticleDOI
Early Administration of Low-Dose Aspirin for the Prevention of Preterm and Term Preeclampsia: A Systematic Review and Meta-Analysis
Stéphanie Roberge,Pia M. Villa,Kypros H. Nicolaides,Yves Giguère,Merja Vainio,Abdelouahab Bakthi,Alaa Ebrashy,Emmanuel Bujold +7 more
TL;DR: Low-dose aspirin administrated at or before 16 weeks of gestation reduces the risk of preterm but not term preeclampsia, according to a systematic review and meta-analysis of randomized controlled trials.
Journal ArticleDOI
Prevention of perinatal death and adverse perinatal outcome using low-dose aspirin: a meta-analysis
TL;DR: To compare early vs late administration of low‐dose aspirin on the risk of perinatal death and adversePerinatal outcome, a large number of patients with at-risk children were referred for treatment with aspirin.
Journal ArticleDOI
Early administration of low-dose aspirin for the prevention of severe and mild preeclampsia: a systematic review and meta-analysis.
Stéphanie Roberge,Yves Giguère,Pia M. Villa,Kypros H. Nicolaides,Merja Vainio,Jean-Claude Forest,Peter von Dadelzen,Daniel Vaiman,Sylvie Tapp,Emmanuel Bujold +9 more
TL;DR: Low-dose aspirin initiated at or before 16 weeks reduces the risk of severe preeclampsia, but not mild preeclamping, and when compared with controls, aspirin started at ≤16 weeks was associated with a significant reduction in severe preeClampsia.
Journal ArticleDOI
An epigenetic clock for gestational age at birth based on blood methylation data.
Anna K. Knight,Jeffrey M. Craig,Christiane Theda,Marie Bækvad-Hansen,Jonas Bybjerg-Grauholm,Christine Søholm Hansen,Mads V. Hollegaard,David M. Hougaard,Preben Bo Mortensen,Shantel Weinsheimer,Thomas Werge,Patricia A. Brennan,Joseph F. Cubells,D. Jeffrey Newport,Zachary N. Stowe,Jeanie L.Y. Cheong,Philippa Dalach,Lex W. Doyle,Yuk Jing Loke,Andrea A. Baccarelli,Allan C. Just,Robert O. Wright,Mara Téllez-Rojo,Katherine Svensson,Letizia Trevisi,Elizabeth M. Kennedy,Elisabeth B. Binder,Elisabeth B. Binder,Stella Iurato,Darina Czamara,Katri Räikkönen,Jari Lahti,Anu-Katriina Pesonen,Eero Kajantie,Eero Kajantie,Pia M. Villa,Hannele Laivuori,Esa Hämäläinen,Hea Jin Park,Lynn B. Bailey,Sasha E. Parets,Varun Kilaru,Ramkumar Menon,Steve Horvath,Nicole R. Bush,Kaja Z. LeWinn,Frances A. Tylavsky,Karen N. Conneely,Alicia K. Smith +48 more
TL;DR: DNA methylation can be used to accurately estimate gestational age at or near birth and may provide additional information relevant to developmental stage and may increase accuracy in the testing of hypotheses related to developmental age and other early life circumstances.
Journal ArticleDOI
Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a meta-analysis of randomised trials
Pia M. Villa,Eero Kajantie,Katri Räikkönen,Anu-Katriina Pesonen,Esa Hämäläinen,Merja Vainio,P. Taipale,Hannele Laivuori +7 more
TL;DR: The aim is to study the effect of aspirin in the prevention of pre‐eclampsia in high‐risk women and to establish a biomarker for aspirin use in pregnancy.